EcoDrugPlus

Sem1 26s Proteasome Subunit

Ensembl ID : ENSPCTG00005004135
Gene Symbol: SEM1
2 Cross references
155 Possible Orthologues:

Tek Receptor Tyrosine Kinase

Ensembl ID : ENSPCTG00005017578
Gene Symbol: TEK
3 Cross references
164 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSPCTG00005002117
Gene Symbol: TTK
1 Cross references
203 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSPCTG00005012255
Gene Symbol: UGCG
3 Cross references
211 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSPCTG00005017702
Gene Symbol: YES1
1 Cross references
269 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSPCTG00005020064
Gene Symbol: ADORA1
1 Cross references
267 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSPCTG00005017084
Gene Symbol: ADORA2A
1 Cross references
260 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSPCTG00005015067
Gene Symbol: ADA
3 Cross references
216 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSPCTG00005001727
Gene Symbol: ADRA1A
3 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSPCTG00005011369
Gene Symbol: ADRA2B
3 Cross references
219 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSPCTG00005017090
Gene Symbol: ADRA2C
1 Cross references
227 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSPCTG00005019183
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).